- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Virology
Volume 2011 (2011), Article ID 782353, 6 pages
No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population
1Section of Infectious Diseases, Jefferiss Research Trust Laboratories, Imperial College London, St Mary's Campus, London W2 1PG, UK
2Transfusion Microbiology R&D, National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale, London NW9 5BG, UK
3Centre for Pathology, Hammersmith Hospital, Imperial College Health Network NHS Trust, 115 1st Floor, L Block, London W12 0HS, UK
4Urology Department, St Mary's Hospital, Imperial College Healthcare NHS Trust, London W2 1NY, UK
5Histopathology Department, St Mary's Hospital, Imperial College London, London W2 1NY, UK
6Department of Urology, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Toyko 105-8461, Japan
7Consultant Urologist, Vedanayagam Hospital, RS Puram, Coimbatore-2 641002, India
8Blood Borne Viruses Unit, Viralus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
Received 17 March 2011; Accepted 31 March 2011
Academic Editor: Yoshinao Kubo
Copyright © 2011 Mark James Robinson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. Urisman, R. J. Molinaro, N. Fischer et al., “Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant,” PLoS Pathogens, vol. 2, no. 3, pp. 211–225, 2006.
- R. Schlaberg, D. J. Choe, K. R. Brown, H. M. Thaker, and I. R. Singh, “XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 38, pp. 16351–16356, 2009.
- A. L. Aloia, K. S. Sfanos, W. B. Isaacs et al., “XMRV: a new virus in prostate cancer?” Cancer Research, vol. 70, no. 24, pp. 10028–10033, 2010.
- S. Sabunciyan, N. Mandelberg, C. S. Rabkin, R. Yolken, and R. Viscidi, “No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls,” Molecular and Cellular Probes, vol. 25, no. 2-3, pp. 134–136, 2011.
- N. Fischer, O. Hellwinkel, C. Schulz et al., “Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer,” Journal of Clinical Virology, vol. 43, no. 3, pp. 277–283, 2008.
- F. R. D'Arcy, A. Foley, L. Perry, et al., “No evidence of XMRV in Irish prostate cancer patients with the R462Q mutations,” European Urology, vol. 7, supplement 271, 2008.
- O. Hohn, H. Krause, P. Barbarotto et al., “Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients,” Retrovirology, vol. 6, article 92, 2009.
- B. P. Danielson, G. E. Ayala, and J. T. Kimata, “Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1470–1477, 2010.
- V. C. Lombardi, F. W. Ruscetti, J. D. Gupta et al., “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome,” Science, vol. 326, no. 5952, pp. 585–589, 2009.
- J. A. Mikovits, V. C. Lombardi, M. A. Pfost, K. S. Hagen, and F. W. Ruscetti, “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome,” Virulence, vol. 1, no. 5, pp. 386–390, 2010.
- S.-C. Lo, N. Pripuzova, B. Li et al., “Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15874–15879, 2010.
- O. Erlwein, S. Kaye, M. Robinson, and M. McClure, “Chronic fatigue syndrome: xenotropic murine leukemia virus-related virus, murine leukemia virus, both, or neither?” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, p. E161, 2010.
- W. M. Switzer, H. Jia, O. Hohn et al., “Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States,” Retrovirology, p. 57, article 57, 2010.
- O. Erlwein, S. Kaye, M. O. McClure et al., “Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome,” PLoS One, vol. 5, no. 1, Article ID e8519, 2010.
- H. C. T. Groom, V. C. Boucherit, K. Makinson et al., “Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome,” Retrovirology, vol. 7, article no. 10, 2010.
- P. Hong, J. Li, and Y. Li, “Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome,” Virology Journal, vol. 7, article 224, 2010.
- F. J. van Kuppeveld, A. S. de Jong, K. H. Lanke et al., “Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort,” BMJ, vol. 340, p. c1018, 2010.
- W. M. Switzer, H. Jia, O. Hohn et al., “Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States,” Retrovirology, vol. 7, article 57, 2010.
- T. J. Henrich, J. Z. Li, D. Felsenstein et al., “Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1478–1481, 2010.
- C. R. Flowers, R. Sinha, and J. M. Vose, “Improving outcomes for patients with diffuse large B-cell lymphoma,” CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 393–408, 2010.
- S. G. Fisher and R. I. Fisher, “The epidemiology of non-Hodgkin's lymphoma,” Oncogene, vol. 23, no. 38, pp. 6524–6534, 2004.
- Y. Allory, D. Challine, C. Haioun et al., “Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution,” American Journal of Surgical Pathology, vol. 25, no. 7, pp. 865–874, 2001.
- A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz, “HIV-associated lymphomas and gamma-herpesviruses,” Blood, vol. 113, no. 6, pp. 1213–1224, 2009.
- H. H. Wong and J. Wang, “Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly,” Leukemia and Lymphoma, vol. 50, no. 3, pp. 335–340, 2009.
- A. Carbone, A. Gloghini, and G. Dotti, “EBV-associated lymphoproliferative disorders: classification and treatment,” Oncologist, vol. 13, no. 5, pp. 577–585, 2008.
- D. A. Thorley-Lawson and A. Gross, “Persistence of the Epstien-Barr Virus and the origins of associated lymphomas,” New England Journal of Medicine, vol. 350, no. 13, pp. 1328–1337, 2004.
- G. P. Taylor and M. Matsuoka, “Natural history of adult T-cell leukemia/lymphoma and approaches to therapy,” Oncogene, vol. 24, no. 39, pp. 6047–6057, 2005.
- M. J. Robinson, O. W. Erlwein, S. Kaye et al., “Mouse DNA contamination in human tissue tested for XMRV,” Retrovirology, vol. 7, article 108, 2010.
- B. Oakes, A. K. Tai, O. Cingöz et al., “Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences,” Retrovirology, vol. 7, article 109, 2010.
- E. Sato, R. A. Furuta, and T. Miyazawa, “An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV,” Retrovirology, vol. 7, article 110, 2010.
- S. Hué, E. R. Gray, A. Gall et al., “Disease-associated XMRV sequences are consistent with laboratory contamination,” Retrovirology, vol. 7, article 111, 2010.
- A. Dupressoir and T. Heidmann, “Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice,” Oncogene, vol. 14, no. 24, pp. 2951–2958, 1997.
- A. L. McCormick, R. H. Brown, M. E. Cudkowicz, A. Al-Chalabi, and J. A. Garson, “Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate,” Neurology, vol. 70, no. 4, pp. 278–283, 2008.
- C. Ratti, G. Budge, L. Ward, G. Clover, C. Rubies-Autonell, and C. Henry, “Detection and relative quantitation of Soil-borne cereal mosaic virus (SBCMV) and Polymyxa graminis in winter wheat using real-time PCR (TaqMan®),” Journal of Virological Methods, vol. 122, no. 1, pp. 95–103, 2004.
- R. B. Ferns and J. A. Garson, “Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control,” Journal of Virological Methods, vol. 135, no. 1, pp. 102–108, 2006.
- J. P. Stoye, R. H. Silverman, C. A. Boucher, and S. F. J. Le Grice, “The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop,” Retrovirology, vol. 7, article 113, 2010.
- R. A. Smith, “Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses,” Retrovirology, vol. 7, article 112, 2010.
- Editorial, “Cause for concern,” Nature, vol. 471, p. 366, 2011.
- L. Menéndez-Arias, “Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome,” Reviews in Medical Virology, vol. 21, no. 1, pp. 3–17, 2011.
- P. W. Tuke, K. I. Tettmar, A. Tamuri, J. P. Stoye, and R. S. Tedder, “PCR Master Mixes Harbour Murine DNA Sequences,” Caveat Emptor! PLoS ONE, vol. 6, no. 5, p. e19953, 2011.
- J. A. Garson, P. Kellam, and G. J. Towers, “Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection,” Retrovirology, vol. 8, article 13, 2011.
- J. Cohen, “Retrovirology: more negative data for link between mouse virus and human disease,” Science, vol. 331, no. 6022, pp. 1253–1254, 2011.
- R. A. Weiss, “A cautionary tale of virus and disease,” BMC Biology, vol. 8, article 124, 2010.